Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 245

1.

Clinical Inference of Serum and Bone Sclerostin Levels in Patients with End-Stage Kidney Disease.

Maré A, Verhulst A, Cavalier E, Delanaye P, Behets GJ, Meijers B, Kuypers D, D'Haese PC, Evenepoel P.

J Clin Med. 2019 Nov 20;8(12). pii: E2027. doi: 10.3390/jcm8122027.

2.

Bone biomarkers in de novo renal transplant recipients.

Evenepoel P, Cavalier E, D'Haese PC.

Clin Chim Acta. 2019 Nov 14. pii: S0009-8981(19)32099-6. doi: 10.1016/j.cca.2019.10.035. [Epub ahead of print]

PMID:
31734147
3.

Reply to: Poor Vitamin K Status in Chronic Kidney Disease: An Indirect Indicator of Hip Fragility.

Evenepoel P, Laurent MR.

J Bone Miner Res. 2019 Aug;34(8):1544-1545. doi: 10.1002/jbmr.3753. Epub 2019 Jul 26. No abstract available.

PMID:
31348841
4.

Etelcalcetide Is Effective at All Levels of Severity of Secondary Hyperparathyroidism in Hemodialysis Patients.

Cunningham J, Block GA, Chertow GM, Cooper K, Evenepoel P, Iles J, Sun Y, Ureña-Torres P, Bushinsky DA.

Kidney Int Rep. 2019 Apr 16;4(7):987-994. doi: 10.1016/j.ekir.2019.04.010. eCollection 2019 Jul.

5.

Intestinal microbiome and fitness in kidney disease.

Meijers B, Evenepoel P, Anders HJ.

Nat Rev Nephrol. 2019 Sep;15(9):531-545. doi: 10.1038/s41581-019-0172-1. Epub 2019 Jun 26. Review.

PMID:
31243394
6.

The Bone after Kidney Transplantation.

Drüeke TB, Evenepoel P.

Clin J Am Soc Nephrol. 2019 Jun 7;14(6):795-797. doi: 10.2215/CJN.04940419. Epub 2019 May 14. No abstract available.

PMID:
31088852
7.

Novel insights into parathyroid hormone: report of The Parathyroid Day in Chronic Kidney Disease.

Ureña-Torres PA, Vervloet M, Mazzaferro S, Oury F, Brandenburg V, Bover J, Cavalier E, Cohen-Solal M, Covic A, Drüeke TB, Hindié E, Evenepoel P, Frazão J, Goldsmith D, Kazama JJ, Cozzolino M, Massy ZA; ERA-EDTA CKD-MBD Working Group.

Clin Kidney J. 2018 Jul 20;12(2):269-280. doi: 10.1093/ckj/sfy061. eCollection 2019 Apr.

8.

Indoxyl Sulfate and p-Cresyl Sulfate Promote Vascular Calcification and Associate with Glucose Intolerance.

Opdebeeck B, Maudsley S, Azmi A, De Maré A, De Leger W, Meijers B, Verhulst A, Evenepoel P, D'Haese PC, Neven E.

J Am Soc Nephrol. 2019 May;30(5):751-766. doi: 10.1681/ASN.2018060609. Epub 2019 Apr 2.

PMID:
30940651
9.

Bone mineral density, bone turnover markers, and incident fractures in de novo kidney transplant recipients.

Evenepoel P, Claes K, Meijers B, Laurent MR, Bammens B, Naesens M, Sprangers B, Pottel H, Cavalier E, Kuypers D.

Kidney Int. 2019 Jun;95(6):1461-1470. doi: 10.1016/j.kint.2018.12.024. Epub 2019 Mar 4.

PMID:
30922664
10.

A distinct bone phenotype in ADPKD patients with end-stage renal disease.

Evenepoel P, Claes K, Cavalier E, Meijers B, Stenvinkel P, Behets G, Jankowska M, D'Haese P, Bammens B.

Kidney Int. 2019 Feb;95(2):412-419. doi: 10.1016/j.kint.2018.09.018.

PMID:
30665572
11.

Poor Vitamin K Status Is Associated With Low Bone Mineral Density and Increased Fracture Risk in End-Stage Renal Disease.

Evenepoel P, Claes K, Meijers B, Laurent M, Bammens B, Naesens M, Sprangers B, Pottel H, Cavalier E, Kuypers D.

J Bone Miner Res. 2019 Feb;34(2):262-269. doi: 10.1002/jbmr.3608. Epub 2018 Nov 14.

PMID:
30427544
12.

Natural history of mineral metabolism, bone turnover and bone mineral density in de novo renal transplant recipients treated with a steroid minimization immunosuppressive protocol.

Evenepoel P, Claes K, Meijers B, Laurent MR, Bammens B, Naesens M, Sprangers B, Cavalier E, Kuypers D.

Nephrol Dial Transplant. 2018 Oct 17. doi: 10.1093/ndt/gfy306. [Epub ahead of print]

PMID:
30339234
13.

Variations of sclerostin with other bone biomarkers over a one-year period in hemodialysis patients.

Paquot F, Delanaye P, Warling X, Moonen M, Smelten N, Jouret F, Krzesinski JM, Maillard N, Pottel H, Evenepoel P, Cavalier E.

Clin Chim Acta. 2018 Nov;486:183-184. doi: 10.1016/j.cca.2018.08.003. Epub 2018 Aug 4. No abstract available.

14.

Intestinal Barrier Function in Chronic Kidney Disease.

Meijers B, Farré R, Dejongh S, Vicario M, Evenepoel P.

Toxins (Basel). 2018 Jul 19;10(7). pii: E298. doi: 10.3390/toxins10070298. Review.

15.

The gut microbiota metabolite indole alleviates liver inflammation in mice.

Beaumont M, Neyrinck AM, Olivares M, Rodriguez J, de Rocca Serra A, Roumain M, Bindels LB, Cani PD, Evenepoel P, Muccioli GG, Demoulin JB, Delzenne NM.

FASEB J. 2018 Jun 15:fj201800544. doi: 10.1096/fj.201800544. [Epub ahead of print]

16.

Sclerostin in chronic kidney disease-mineral bone disorder think first before you block it!

Brandenburg VM, Verhulst A, Babler A, D'Haese PC, Evenepoel P, Kaesler N.

Nephrol Dial Transplant. 2019 Mar 1;34(3):408-414. doi: 10.1093/ndt/gfy129.

PMID:
29846712
17.

Facing cinacalcet-induced hypocalcemia: sit back and relax?

Evenepoel P, Shroff R.

Kidney Int. 2018 Jun;93(6):1275-1277. doi: 10.1016/j.kint.2018.01.038.

PMID:
29792272
18.

Linking gut microbiota to cardiovascular disease and hypertension: Lessons from chronic kidney disease.

Meijers B, Jouret F, Evenepoel P.

Pharmacol Res. 2018 Jul;133:101-107. doi: 10.1016/j.phrs.2018.04.023. Epub 2018 Apr 30. Review.

19.

Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder: Synopsis of the Kidney Disease: Improving Global Outcomes 2017 Clinical Practice Guideline Update.

Ketteler M, Block GA, Evenepoel P, Fukagawa M, Herzog CA, McCann L, Moe SM, Shroff R, Tonelli MA, Toussaint ND, Vervloet MG, Leonard MB.

Ann Intern Med. 2018 Mar 20;168(6):422-430. doi: 10.7326/M17-2640. Epub 2018 Feb 20.

PMID:
29459980
20.

Sclerostin deficiency modifies the development of CKD-MBD in mice.

Kaesler N, Verhulst A, De Maré A, Deck A, Behets GJ, Hyusein A, Evenepoel P, Floege J, Marx N, Babler A, Kramer I, Kneissel M, Kramann R, Weis D, D'Haese PC, Brandenburg VM.

Bone. 2018 Feb;107:115-123. doi: 10.1016/j.bone.2017.11.015. Epub 2017 Nov 21.

PMID:
29175269
21.

p-cresol sulfate and indoxyl sulfate: some clouds are gathering in the uremic toxin sky.

Evenepoel P, Glorieux G, Meijers B.

Kidney Int. 2017 Dec;92(6):1323-1324. doi: 10.1016/j.kint.2017.06.029.

PMID:
29153138
22.

Sclerostin─A Debutant on the Autosomal Dominant Polycystic Kidney Disease Scene?

Jankowska M, Haarhaus M, Qureshi AR, Lindholm B, Evenepoel P, Stenvinkel P.

Kidney Int Rep. 2017 Jan 10;2(3):481-485. doi: 10.1016/j.ekir.2017.01.001. eCollection 2017 May.

23.

Evidence for Bone and Mineral Metabolism Alterations in Children With Autosomal Dominant Polycystic Kidney Disease.

De Rechter S, Bacchetta J, Godefroid N, Dubourg L, Cochat P, Maquet J, Raes A, De Schepper J, Vermeersch P, Van Dyck M, Levtchenko E, D'Haese P, Evenepoel P, Mekahli D.

J Clin Endocrinol Metab. 2017 Nov 1;102(11):4210-4217. doi: 10.1210/jc.2017-01157.

PMID:
29092060
24.

Bone and mineral disorders in chronic kidney disease: implications for cardiovascular health and ageing in the general population.

Covic A, Vervloet M, Massy ZA, Torres PU, Goldsmith D, Brandenburg V, Mazzaferro S, Evenepoel P, Bover J, Apetrii M, Cozzolino M.

Lancet Diabetes Endocrinol. 2018 Apr;6(4):319-331. doi: 10.1016/S2213-8587(17)30310-8. Epub 2017 Oct 16. Review.

PMID:
29050900
25.

Sclerostin and chronic kidney disease: the assay impacts what we (thought to) know.

Delanaye P, Paquot F, Bouquegneau A, Blocki F, Krzesinski JM, Evenepoel P, Pottel H, Cavalier E.

Nephrol Dial Transplant. 2018 Aug 1;33(8):1404-1410. doi: 10.1093/ndt/gfx282.

PMID:
29048521
26.

Update on the role of bone biopsy in the management of patients with CKD-MBD.

Evenepoel P, Behets GJS, Laurent MR, D'Haese PC.

J Nephrol. 2017 Oct;30(5):645-652. doi: 10.1007/s40620-017-0424-8. Epub 2017 Aug 22. Review.

PMID:
28831679
27.

Executive summary of the 2017 KDIGO Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) Guideline Update: what's changed and why it matters.

Ketteler M, Block GA, Evenepoel P, Fukagawa M, Herzog CA, McCann L, Moe SM, Shroff R, Tonelli MA, Toussaint ND, Vervloet MG, Leonard MB.

Kidney Int. 2017 Jul;92(1):26-36. doi: 10.1016/j.kint.2017.04.006. Review. Erratum in: Kidney Int. 2017 Dec;92(6):1558.

28.

Circulating levels of sclerostin but not DKK1 associate with laboratory parameters of CKD-MBD.

Behets GJ, Viaene L, Meijers B, Blocki F, Brandenburg VM, Verhulst A, D'Haese PC, Evenepoel P.

PLoS One. 2017 May 11;12(5):e0176411. doi: 10.1371/journal.pone.0176411. eCollection 2017.

29.

Biomarkers Predicting Bone Turnover in the Setting of CKD.

Evenepoel P, Cavalier E, D'Haese PC.

Curr Osteoporos Rep. 2017 Jun;15(3):178-186. doi: 10.1007/s11914-017-0362-3. Review.

PMID:
28429254
30.

A noninferiority trial comparing a heparin-grafted membrane plus citrate-containing dialysate versus regional citrate anticoagulation: results of the CiTED study.

Meijers B, Metalidis C, Vanhove T, Poesen R, Kuypers D, Evenepoel P.

Nephrol Dial Transplant. 2017 Apr 1;32(4):707-714. doi: 10.1093/ndt/gfw461.

PMID:
28407129
31.

Bone biopsy practice patterns across Europe: the European renal osteodystrophy initiative-a position paper.

Evenepoel P, D'Haese P, Bacchetta J, Cannata-Andia J, Ferreira A, Haarhaus M, Mazzaferro S, Lafage Proust MH, Salam S, Spasovski G, Cozzolino M; ERA-EDTA Working Group on CKD-MBD.

Nephrol Dial Transplant. 2017 Oct 1;32(10):1608-1613. doi: 10.1093/ndt/gfw468.

32.

1β,25-Dihydroxyvitamin D3: A new vitamin D metabolite in human serum.

Pauwels S, Jans I, Billen J, Heijboer A, Verstuyf A, Carmeliet G, Mathieu C, Maestro M, Waelkens E, Evenepoel P, Bouillon R, Vanderschueren D, Vermeersch P.

J Steroid Biochem Mol Biol. 2017 Oct;173:341-348. doi: 10.1016/j.jsbmb.2017.02.004. Epub 2017 Feb 11.

PMID:
28193495
33.

Magnesium-based interventions for normal kidney function and chronic kidney disease.

Massy ZA, Nistor I, Apetrii M, Brandenburg VM, Bover J, Evenepoel P, Goldsmith D, Mazzaferro S, Urena-Torres P, Vervloet MG, Cozzolino M, Covic A, Era-Edta OB.

Magnes Res. 2016 Apr 1;29(4):126-140. doi: 10.1684/mrh.2016.0412. Review.

34.

Ligand trap for the activin type IIA receptor. The long-sought drug to overcome the calcification paradox in CKD?

Verhulst A, Evenepoel P, D'Haese PC.

Kidney Int. 2017 Jan;91(1):11-13. doi: 10.1016/j.kint.2016.09.050.

PMID:
28003078
35.

Bone histomorphometry in de novo renal transplant recipients indicates a further decline in bone resorption 1 year posttransplantation.

Evenepoel P, Behets GJ, Viaene L, D'Haese PC.

Kidney Int. 2017 Feb;91(2):469-476. doi: 10.1016/j.kint.2016.10.008. Epub 2016 Dec 18.

PMID:
27998642
36.

The gut-kidney axis.

Evenepoel P, Poesen R, Meijers B.

Pediatr Nephrol. 2017 Nov;32(11):2005-2014. doi: 10.1007/s00467-016-3527-x. Epub 2016 Nov 15. Review.

PMID:
27848096
37.

Microbiota-Derived Phenylacetylglutamine Associates with Overall Mortality and Cardiovascular Disease in Patients with CKD.

Poesen R, Claes K, Evenepoel P, de Loor H, Augustijns P, Kuypers D, Meijers B.

J Am Soc Nephrol. 2016 Nov;27(11):3479-3487. Epub 2016 May 26.

38.

Parathyroid hormone metabolism and signaling in health and chronic kidney disease.

Evenepoel P, Bover J, Ureña Torres P.

Kidney Int. 2016 Dec;90(6):1184-1190. doi: 10.1016/j.kint.2016.06.041. Epub 2016 Sep 18. Review.

PMID:
27653840
39.

Mineral metabolism disturbances in kidney donors: smoke, no fire (yet).

Evenepoel P, Naesens M.

Kidney Int. 2016 Oct;90(4):734-6. doi: 10.1016/j.kint.2016.07.001.

PMID:
27633867
40.

Oxidative Stress in Chronic Kidney Disease.

Scholze A, Jankowski J, Pedraza-Chaverri J, Evenepoel P.

Oxid Med Cell Longev. 2016;2016:8375186. doi: 10.1155/2016/8375186. Epub 2016 Aug 8. No abstract available.

41.

A liquid chromatography - tandem mass spectrometry method to measure a selected panel of uremic retention solutes derived from endogenous and colonic microbial metabolism.

de Loor H, Poesen R, De Leger W, Dehaen W, Augustijns P, Evenepoel P, Meijers B.

Anal Chim Acta. 2016 Sep 14;936:149-56. doi: 10.1016/j.aca.2016.06.057. Epub 2016 Jul 2.

PMID:
27566350
42.

Decreased Circulating Sclerostin Levels in Renal Transplant Recipients With Persistent Hyperparathyroidism.

Evenepoel P, Claes K, Viaene L, Bammens B, Meijers B, Naesens M, Sprangers B, Kuypers D.

Transplantation. 2016 Oct;100(10):2188-93. doi: 10.1097/TP.0000000000001311.

PMID:
27379556
43.

The Case | Hypercalcemia in a child with chronic kidney disease.

De Rechter S, Levtchenko E, Evenepoel P, Mekahli D.

Kidney Int. 2016 Jul;90(1):233-4. doi: 10.1016/j.kint.2015.12.060. No abstract available.

PMID:
27312459
44.

Adverse Effects of Proton Pump Inhibitors in Chronic Kidney Disease.

Poesen R, Meijers B, Evenepoel P.

JAMA Intern Med. 2016 Jun 1;176(6):867-8. doi: 10.1001/jamainternmed.2016.1854. No abstract available.

PMID:
27273496
45.

Clinical case report: a rare cause of acute kidney failure - tissue is the issue.

Heggermont WA, Verhoef G, Evenepoel P, Sprangers B, Lerut E, Tousseyn T, Claes K.

Acta Clin Belg. 2017 Jun;72(3):201-204. doi: 10.1080/17843286.2016.1178967. Epub 2016 May 17.

PMID:
27253186
46.

The Influence of Prebiotic Arabinoxylan Oligosaccharides on Microbiota Derived Uremic Retention Solutes in Patients with Chronic Kidney Disease: A Randomized Controlled Trial.

Poesen R, Evenepoel P, de Loor H, Delcour JA, Courtin CM, Kuypers D, Augustijns P, Verbeke K, Meijers B.

PLoS One. 2016 Apr 21;11(4):e0153893. doi: 10.1371/journal.pone.0153893. eCollection 2016.

47.

Validation of commercially available ELISAs for the detection of circulating sclerostin in hemodialysis patients.

Mause SF, Deck A, Hennies M, Kaesler N, Evenepoel P, Boisvert WA, Janssen U, Brandenburg VM.

Discoveries (Craiova). 2016;4(1):e55.

48.

Metabolism, Protein Binding, and Renal Clearance of Microbiota-Derived p-Cresol in Patients with CKD.

Poesen R, Evenepoel P, de Loor H, Kuypers D, Augustijns P, Meijers B.

Clin J Am Soc Nephrol. 2016 Jul 7;11(7):1136-44. doi: 10.2215/CJN.00160116. Epub 2016 Apr 15.

49.

Lack of evidence does not justify neglect: how can we address unmet medical needs in calciphylaxis?

Brandenburg VM, Evenepoel P, Floege J, Goldsmith D, Kramann R, Massy Z, Mazzaferro S, Schurgers LJ, Sinha S, Torregrosa V, Ureña-Torres P, Vervloet M, Cozzolino M; ERA-EDTA Working Group on CKD-MBD and EUCALNET.

Nephrol Dial Transplant. 2016 Aug;31(8):1211-9. doi: 10.1093/ndt/gfw025. Epub 2016 Mar 22.

PMID:
27005994
50.

Vitamin K Dependent Protection of Renal Function in Multi-ethnic Population Studies.

Wei FF, Drummen NE, Schutte AE, Thijs L, Jacobs L, Petit T, Yang WY, Smith W, Zhang ZY, Gu YM, Kuznetsova T, Verhamme P, Allegaert K, Schutte R, Lerut E, Evenepoel P, Vermeer C, Staessen JA.

EBioMedicine. 2016 Jan 13;4:162-9. doi: 10.1016/j.ebiom.2016.01.011. eCollection 2016 Feb.

Supplemental Content

Loading ...
Support Center